KR20130017431A - An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain - Google Patents
An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain Download PDFInfo
- Publication number
- KR20130017431A KR20130017431A KR1020110079838A KR20110079838A KR20130017431A KR 20130017431 A KR20130017431 A KR 20130017431A KR 1020110079838 A KR1020110079838 A KR 1020110079838A KR 20110079838 A KR20110079838 A KR 20110079838A KR 20130017431 A KR20130017431 A KR 20130017431A
- Authority
- KR
- South Korea
- Prior art keywords
- persimmon
- wine
- fermentation
- yeast
- present
- Prior art date
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 71
- 239000000843 powder Substances 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 229940057059 monascus purpureus Drugs 0.000 title claims abstract description 7
- 244000113306 Monascus purpureus Species 0.000 title abstract 3
- 235000002322 Monascus purpureus Nutrition 0.000 title abstract 3
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 50
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 42
- 238000000855 fermentation Methods 0.000 claims abstract description 24
- 230000004151 fermentation Effects 0.000 claims abstract description 24
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 21
- 108010010803 Gelatin Proteins 0.000 claims abstract description 14
- 229920000159 gelatin Polymers 0.000 claims abstract description 14
- 239000008273 gelatin Substances 0.000 claims abstract description 14
- 235000019322 gelatine Nutrition 0.000 claims abstract description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 12
- 235000013376 functional food Nutrition 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000006188 syrup Substances 0.000 claims abstract description 4
- 235000020357 syrup Nutrition 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract 3
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract 2
- 235000018553 tannin Nutrition 0.000 claims description 12
- 229920001864 tannin Polymers 0.000 claims description 12
- 239000001648 tannin Substances 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 230000003293 cardioprotective effect Effects 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims description 2
- 230000000593 degrading effect Effects 0.000 claims description 2
- 230000032683 aging Effects 0.000 claims 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 210000002064 heart cell Anatomy 0.000 abstract description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 5
- 239000008103 glucose Substances 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 3
- 239000001963 growth medium Substances 0.000 abstract description 3
- 239000012141 concentrate Substances 0.000 abstract description 2
- 235000008504 concentrate Nutrition 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 238000004108 freeze drying Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000007789 sealing Methods 0.000 abstract description 2
- 239000000306 component Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 235000012041 food component Nutrition 0.000 abstract 1
- 239000005428 food component Substances 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 108010038851 tannase Proteins 0.000 abstract 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 30
- 238000011282 treatment Methods 0.000 description 27
- 238000004128 high performance liquid chromatography Methods 0.000 description 19
- 235000004515 gallic acid Nutrition 0.000 description 15
- 229940074391 gallic acid Drugs 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 150000008442 polyphenolic compounds Chemical class 0.000 description 10
- 235000013824 polyphenols Nutrition 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 9
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 9
- 235000005487 catechin Nutrition 0.000 description 9
- 229950001002 cianidanol Drugs 0.000 description 9
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 8
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 244000055850 Diospyros virginiana Species 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 4
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 210000004413 cardiac myocyte Anatomy 0.000 description 4
- 230000030833 cell death Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 4
- 235000012734 epicatechin Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 2
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 241000723267 Diospyros Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940026314 red yeast rice Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- JFTUSFFYSRNFBA-UHFFFAOYSA-N 3-amino-5-nitrosalicylic acid Chemical compound NC1=CC([N+]([O-])=O)=CC(C(O)=O)=C1O JFTUSFFYSRNFBA-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000538804 Lethrinus haematopterus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 125000004403 catechin group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000013379 physicochemical characterization Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012599 radical scavenging assay Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 홍국균을 이용한 감와인 농축파우더를 유효성분으로 함유하는 항산화 및 심장세포 보호 기능성 식품 조성물에 관한 것이다.
The present invention relates to an antioxidant and heart cell protective functional food composition containing a concentrated powder of persimmon wine using red yeast bacteria as an active ingredient.
최근 국민 생활수준의 향상과 더불어 건강지향적 식생활을 추구하는 경향이 두드러지게 나타나고 있는데 그 일환으로 천연지향적 식품을 선호하고 웰빙식품 등 식품선택이 안전성을 우선한 고품질식품에 관심이 높아지고 있다.Recently, the trend of pursuing a health-oriented diet with the improvement of the standard of living of the people has been prominent. As a part of this, there is increasing interest in high-quality foods that prefer natural-oriented foods and safety choices such as well-being foods.
이러한 경향에 따라 소비자들의 주류의 선택도 고도(高度) 알코올에서 저도 알코올 소비로 변화되고 있으며 또한 건강과 관련된 주류의 소비가 증가하고 있으며, 그 일예로써 소주가 저도화되고, 막걸리의 소비와 포도주의 수입이 급증하고 있다. 이러한 경향에 맞추어 본 발명자는 지역 특산 감을 이용하여 독특한 향과 맛을 가진 감와인을 개발한 바 있다. 그러나 감와인에 대한 축적된 기술이 미흡하고 그 품질이나 기능성 성분 및 건강 관련 효능 등이 대중들에게 넓게 알려지지 않았으며, 따라서 감와인 산업의 발전과 대량소비를 위해서 지속적인 품질 개선과 함유성분 및 그 효능에 대한 과학적 평가가 반드시 필요하였다.This trend is changing the consumer's choice of liquor from high alcohol to low alcohol consumption, and the consumption of health-related alcoholic beverages is increasing, for example, soju is lowered, makgeolli consumption and wine Income is skyrocketing. In line with this trend, the inventors have developed persimmon wines with unique aromas and flavors using local persimmons. However, the accumulated technology of Gam wine is insufficient and its quality, functional ingredients and health related effects are not widely known to the public. Scientific evaluation was necessary.
감은 동양권의 특산물로서 그중에서도 중국, 일본, 우리나라에서만 나는 특유의 단맛이 함유된 과일이다. 감나무는 낙엽활엽교목으로 전국 각지의 촌락에 자라고 있다. 논산 양촌의 감나무들은 수령이 최소 30년 이상 된 고목들이다. 북서계절풍이 강해 통풍이 잘되고, 산으로 둘러싸여 먼지가 날리지 않는 깨끗한 곳으로 예로부터 노을이 아름다워 논산, 햇볕이 잘 들어서 양촌이라 불렀다. 천혜의 자연조건으로 양촌 곶감은 인공건조가 아닌, 자연 천일건조로 만들어지고 있다. 곶감으로 잘 알려진 양촌 두리감은 당도, 비타민 C와 카로티노이드 함량이 높아 영양학적으로 유익한 과일이며 특히, 떫은 맛을 내는 탄닌은 항산화 능력이 뛰어나 건강에 매우 유익한 과일이다. 탄닌의 작용은 아세트알데하이드와 결합하여 숙취를 해소하는 효과도 있다. "감을 먹으면 술이 빨리 깬다"는 말이 있는 것도 이런 이유에서이다. 한 동안 외국 과일에 밀려서 재배가 등한시 된 적도 있지만, 동양 고유의 은은한 맛과, 뛰어난 건강 기능성으로 다시 전성기를 맞고 있다.Persimmon is a specialty of the Asian region, and it is a fruit that contains unique sweetness only in China, Japan, and Korea. Persimmon is a deciduous broad-leaved arboreous tree growing in villages all over the country. Persimmon trees in Yangsan Nonchon are trees that are at least 30 years old. It is a clean place where the northwest season is well-ventilated, and it is a clean place surrounded by mountains, where dust is not blown away. Due to the natural condition of natural beauty, Yangchon dried persimmon is made by natural sun drying, not artificial drying. Known as dried persimmon, Yangchon Durigam is a nutritious fruit with high sugar content, vitamin C and carotenoids. Especially, tannin, which has a rich taste, is very fruitful because of its excellent antioxidant capacity. The action of tannins is also associated with acetaldehyde, which has the effect of eliminating hangovers. This is why there is a saying that "drink persimmons break quickly." Although it has been neglected to be cultivated by foreign fruits for some time, it is in full bloom again with its unique taste and excellent health function.
홍국은 예로부터 건강에 유익한 누룩으로 평가되어 왔다. 중국에서 예로부터 양조 원료로 사용됐고 중국 고대 의약서에도 약재로 기록되어 있다. 중국 한나라의 황제 유방이 처음 황실 음식으로 채택하여 혈행을 개선시키는 한약재로 사용하였고, 조선 중기 중국 사신에 의해 우리나라에 전래되어 산후 어혈 해소제로 사용되었다. '본초강목(本草綱目)'에는 '소화를 돕고 피를 소생케하며, 비장을 강하게 하고 위를 조절하며, 여인의 피를 소생케하여 부인병을 고친다.' 고 기록되어 있고, '동의보감(東毅寶鑑)'에는 '홍국은 피를 잘 돌게 하고 음식이 소화되게 하며 이질을 멎게 하는 신국' 이라고 기술되어 있다. 홍국은 식품의약안전청에 건강기능식품으로 등록되어있으며, 그 효능이 과학적으로 입증되어 미국에서는 의약품으로도 판매되고 있다. 최근까지 연구된 홍국의 효능은 혈압강하, 향균, 항암, 항산화 기능, 혈당강하 작용이 있는 것으로 입증되었고 특히, 홍국균이 생성하는 "모나콜린-K (Monakolin-K)"는 혈중 콜레스테롤 함량을 낮추는데 큰 효과가 있는 것으로 나타났다. 본 발명자가 개발하는 감와인은 상기 홍국균을 와인제조에 적용하여 전통과 과학을 접목시킨 건강 기능성이 입증된 새로운 와인이다. Red yeast has long been regarded as the leaven that is beneficial to health. It has been used as a raw material for brewing in China since ancient times, and it is recorded in Chinese ancient medicine. The Chinese emperor's breast was first used as an imperial food and used as a Chinese medicine to improve blood circulation. In the main herb 本草綱目, it helps digestion, revitalizes the blood, strengthens the spleen, regulates the stomach, and revitalizes the woman's blood to cure the disease. 'Dongguk' agrees that the 'Hongguk' is a new country that makes blood flow well, food is digested, and stops dysentery. Hongguk is registered as a dietary supplement by the Food and Drug Administration, and its efficacy has been scientifically proven and sold in the United States. The efficacy of red yeast rice, which has been studied until recently, has been shown to be effective in lowering blood pressure, antibacterial, anti-cancer, antioxidant function, and hypoglycemic activity. Especially, "Monakolin-K" produced by red yeast bacterium has a large effect on lowering blood cholesterol content. It has been shown to be effective. Gam wine developed by the present inventors is a new wine that proved the health functionalities that combine tradition and science by applying the hongguk bacteria to wine production.
인체에 과다한 양의 활성산소는 단백질의 변성이나 생체 내의 지질 산화, DNA의 파괴 등을 일으키게 된다. 본 발명자가 개발한 추시는 양촌의 두리감을 홍국균 및 효모균으로 발효하여, 감이 함유하고 있는 탄닌, 카테킨 등 다량의 폴리페놀 성분이 일반 와인에 비해 높은 농도로 함유되어 있음이 확인되었다. 상기 탄닌, 카테킨 성분은 활성산소를 제거해 주는 항산화능력이 뛰어나 세포의 손상을 방지하여 줄 뿐 아니라, 신규한 기능성 용도를 제공할 수 있다.
Excessive amounts of free radicals in the human body cause protein denaturation, oxidation of lipids in the living body, and destruction of DNA. The present invention developed by the present inventors was fermented with a sense of fermentation of hongchonkyun and yeast bacteria, it was confirmed that a large amount of polyphenol components such as tannin, catechin, etc. contained in the persimmon contained in a higher concentration than ordinary wine. The tannin, catechin component is excellent in the antioxidant capacity to remove the free radicals to prevent damage to the cells, as well as provide new functional use.
본 발명은 상기와 같은 점들을 감안하여 안출한 것으로 본 발명의 목적은 본 발명의 감와인을 유효성분으로 하는 항산화 및 심장세포 보호 기능성 식품을 제공하는 데 있다.
The present invention has been made in view of the above-mentioned matters, and an object of the present invention is to provide an antioxidant and heart cell protective functional food comprising the persimmon wine of the present invention as an active ingredient.
본 발명의 상기 목적은 홍국균의 종균배양액을 폐기되는 감 파쇄액에 접종발효하여 감와인을 제조하는 1차 발효단계와; 착즙, 여과후 포도당과 함께 효모균주를 첨가,공서배양하는 2차 발효단계와; 효소처리하여 감발효주의 숙성단계와; 알코올발효주의 특성을 확인하는 단계와; 본 발명 감와인을 농축, 동결건조하는 단계와 항산화능을 확인하고 평가하는 단계를 통하여 달성하였다.
The above object of the present invention is the primary fermentation step of producing the persimmon wine by inoculating and fermenting the seed culture medium of hongguk spawn in the waste crushed solution; A second fermentation step of adding the yeast strain with glucose after filtration and filtration, and empty culture; Fermentation of persimmon fermented wine by enzymatic treatment; Identifying the properties of the alcoholic fermentation strain; The present invention was achieved through the step of concentrating, lyophilizing and identifying and evaluating antioxidant capacity.
본 발명은 gallic acid 함량이 높아 항산화 기능성 식품 조성물을 제공하는 뛰어난 효과가 있다.
The present invention has a high gallic acid content has an excellent effect of providing an antioxidant functional food composition.
도 1은 본 발명 감와인의 제조공정도이다.
도 2는 본 발명에 따른 Standards의 HPLC 크로마토그램이다.
도 3은 본 발명 감 와인 ‘2-1(2009 2월 생산)’ 제품의 HPLC 크로마토그램이다.
도 4는 본 발명 감 와인 ‘2-2(2010 3월 생산)’ 제품의 HPLC 크로마토그램이다.
도 5는 본 발명 감 와인 본 발명 제품의 HPLC 크로마토그램이다.
도 6은 본 발명에 따른 Standards의 HPLC 크로마토그램이다.
도 7은 본 발명 감와인 제품의 Monacolin K 관련 HPLC 크로마토그램이다.
도 8은 본 발명 감 와인 ‘2-1(2009 2월 생산)’ 제품(효소처리)의 HPLC 크로마토그램이다.
도 9는 본 발명 감 와인 ‘2-2(2010 3월 생산)’ 제품(효소처리)의 HPLC 크로마토그램이다.
도 10은 본 발명 감 와인 ‘추시’ 제품(효소처리)의 HPLC 크로마토그램이다.
도 11은 본 발명 감 와인 ‘2-1(2009년 2월 생산) 젤라틴 0.3중량% 처리’ 제품의 HPLC 크로마토그램이다.
도 12는 본 발명에 따른 Standards의 HPLC 크로마토그램이다.
도 13은 본 발명에 따른 연시 생것의 HPLC 크로마토그램이다.
도 14는 본 발명 감와인 발효 1차 단계(홍국발효)의 HPLC 크로마토그램이다.
도 15는 본 발명 감와인 발효 2차 단계(효모발효)의 HPLC 크로마토그램이다.
도 16은 본 발명 추시와인 (A) 및 추시와인파우더(B)의 항산화 활성도이다.
도 17은 본 발명 추시와인파우더의 심장세포내 활성산소 제거능 평가도이다.
도 18은 본 발명 추시와인의 심장세포 보호 효능평가도이다.
도 19는 본 발명 추시와인 파우더의 Gallic acid와 Monacolin K의 심장세포 보호효능 평가도이다.1 is a manufacturing process diagram of the present invention wine.
2 is an HPLC chromatogram of Standards according to the present invention.
Figure 3 is an HPLC chromatogram of the inventive persimmon wine '2-1 (produced February 2009)'.
4 is an HPLC chromatogram of the inventive persimmon wine '2-2 (March 2010 production)'.
5 is an HPLC chromatogram of the inventive persimmon wine inventive product.
6 is an HPLC chromatogram of Standards according to the present invention.
Figure 7 is a Monacolin K related HPLC chromatogram of the present invention Gam wine.
8 is an HPLC chromatogram of the present invention persimmon wine '2-1 (February 2009 production)' product (enzyme treatment).
Figure 9 is an HPLC chromatogram of the inventive persimmon wine '2-2 (March 2010 production)' product (enzyme treatment).
FIG. 10 is an HPLC chromatogram of the inventive persimmon wine 'tracing' product (enzyme treatment).
FIG. 11 is an HPLC chromatogram of the inventive persimmon wine '2-1 (February 2009) gelatin 0.3 wt% processed' product.
12 is an HPLC chromatogram of Standards according to the present invention.
Figure 13 is an HPLC chromatogram of raw raw materials according to the present invention.
Figure 14 is an HPLC chromatogram of the first step of fermentation of ginseng of the present invention (hongguk fermentation).
15 is an HPLC chromatogram of the second step (fermentation) of the persimmon wine fermentation of the present invention.
Figure 16 is the antioxidant activity of the present invention wine (A) and the additional wine powder (B).
17 is an evaluation of free radical removal ability in the heart cells of the present invention wine powder.
18 is a cardioprotective evaluation of the present invention wine.
Figure 19 is an evaluation of the cardiac protective effect of Gallic acid and Monacolin K of the present invention wine powder.
<< 실시예Example 1> 본 발명 감와인 1> the present invention wine 의of 제조 Produce
본 발명의 감와인의 제조공정은 도 1에 도식화하였다.The manufacturing process of the persimmon wine of this invention is shown in FIG.
모나스커스 퍼프리우스 KCCM 60170 균주를 PDB 배지에 접종하고 30℃에서 24시간 배양하여 홍국균이 1×107cell/mL 되도록 전배양하였다. 낙과 또는 연시(무른 감)를 으깨 얻은 감 파쇄액에 탄닌분해효소 또는 젤라틴을 0.3중량%이하 첨가하고 45℃에서 2시간 또는 1시간 동안 처리한 후 구연산 0.05중량%를 첨가하여 pH 3.6으로 조정하고 다시 메타아황산가리(K2S2O5) 0.15g/L를 첨가하여 아황산(SO2)농도 60ppm을 유지시켜 12시간 밀봉방치하여 살균하였다. 상기 살균한 감펄프에 중량대비 3중량%의 상기 홍국균 전배양액을 접종하여 26℃에서 6일간 1차 발효하였다.Monascus perprius KCCM 60170 strain was inoculated in PDB medium and incubated at 30 ° C. for 24 hours to pre-cultivate erythrocytes to 1 × 10 7 cells / mL. 0.3% by weight or less of tannin dehydrogenase or gelatin was added to the persimmon crushed liquid obtained by mashing the fruit or soft berry (soft persimmon), treated at 45 ° C. for 2 hours or 1 hour, and then adjusted to pH 3.6 by adding 0.05% by weight of citric acid. 0.15 g / L of sulfur metasulfite (K 2 S 2 O 5 ) was added thereto to maintain a concentration of sulfuric acid (SO 2 ) of 60 ppm and sterilized by sealing for 12 hours. The sterilized persimmon pulp was inoculated with 3% by weight of the pre-cultivation of the honggukyun culture medium was fermented primarily at 26 ℃ for 6 days.
상기 발효액을 착즙,여과하고 포도당을 당도 23obrix가 되도록 첨가한 후 효모 Saccharomyces cerevisiae(Wine west, Anchor, Germany)를 전체 중량대비 3중량%를 접종하여 알콜농도 16%에 이를 때까지 2차 발효시키고 탄닌분해효소 또는 젤라틴을 0.3중량%이하 첨가하고 2시간 또는 1시간 동안 처리한 후 숙성하였다.
The fermentation broth was juiced, filtered, and glucose was added so that the sugar content was 23 o brix. The fermentation of the yeast Saccharomyces cerevisiae (Wine west, Anchor, Germany) was inoculated with 3% by weight of the total weight, followed by secondary fermentation until the alcohol concentration reached 16%. After tannin dehydrogenase or gelatin was added at less than 0.3% by weight and treated for 2 hours or 1 hour, the cells were aged.
<< 실험예Experimental Example 1> 1> 알코올 함량 측정Alcohol content measurement
본 발명 감와인 100mL를 취하여 삼각 flask에 옮긴 다음, 동량의 물로 씻어서 flask에 합하고 이를 증류 및 냉각장치에 연결, 가열하여 증류액이 약 80mL가 되면 증류를 중지하고 100mL까지 증류수로 정용하였다. 정용액에 주정계를 사용하여 그 표시도를 읽어 Gay-Lussac 표로서 15℃로 보정하여 알코올 함량으로 나타내었다.
100 ml of the present invention was taken and transferred to an Erlenmeyer flask, washed with an equal amount of water, combined with the flask and connected to a distillation and cooling device, and heated to stop the distillation when the distillate became about 80 mL and distilled water up to 100 mL. The display was read using the alcohol system in the essence solution and the alcohol content was corrected to 15 ° C as a Gay-Lussac table.
<< 실험예Experimental Example 2> 가용성 고형물 2> soluble solids
본 발명 감와인 시료 중 일부를 취하여 굴절당도계(ATAGO Digital Refractometer, Japan)를 사용하여 20℃의 온도에서 °Brix로 측정하였다.
A portion of the sample of the present invention was taken and measured by ° Brix at a temperature of 20 ° C using a refractometer (ATAGO Digital Refractometer, Japan).
<< 실험예Experimental Example 3> 3> pHpH 측정 Measure
본 발명 감와인의 pH는 pH meter(HANNA Instrument, Italy)를 사용하여 직접 시료중에 담구어서 측정하였다.
The pH of the present invention wine was measured by dipping directly in the sample using a pH meter (HANNA Instrument, Italy).
<< 실험예Experimental Example 4> 환원당 정량 4> Reducing Sugar
환원당에 의하여 3,5-dinitrosalicylic acid(DNS)가 환원되어 생성된 3-amino-5-nitrosalicylic acid의 흡광도를 UV/VIS spectrophotometer(Diod-Array) HP 8454으로 550nm에서 측정한다. 별도로 포도당 15~300 ㎍을 함유하는 표준용액의 검량선을 작성하여, 검체중의 환원당량(mg/ml 또는 %)을 구하였다.
Absorbance of 3-amino-5-nitrosalicylic acid produced by reducing 3,5-dinitrosalicylic acid (DNS) by reducing sugar is measured at 550 nm with a UV / VIS spectrophotometer (Diod-Array) HP 8454. Separately, a calibration curve of a standard solution containing 15 to 300 µg of glucose was prepared, and the reducing equivalent (mg / ml or%) in the sample was obtained.
상기 실험예 1~4에 따라 감와인의 이화학적 특성을 분석하기 위하여 본 발명 실시예에 의거 제조된 추시 와인 처리구와 생산시기가 다른 두 제조 와인 처리구의 알코올, 가용성고형물, 환원당, pH의 분석 결과를 [표 1]에 나타내었다. 알코올 함량의 경우 세 처리구 모두 약 16% 정도의 함량을 나타내었고, 가용성고형물과 환원당은 2010년 3월 생산된 처리구가 각각 10.0 °Bx와 0.74%로 다른 처리구들에 비해 다소 낮았다. pH는 본 발명 '추시' 제품이 4.08로 다른 처리구들에 비해 다소 높았다.Analysis results of alcohol, soluble solids, reducing sugars, pH of two wines produced according to the present invention and two different wines produced according to the present invention in order to analyze the physicochemical characteristics of the persimmon wine according to Experimental Examples 1 to 4 above. It is shown in [Table 1]. The alcohol content of all three treatments was about 16%, and the soluble solids and reducing sugars were 10.0 ° Bx and 0.74% in March 2010, respectively. The pH of the 'follow-up' product of the present invention was 4.08, which was somewhat higher than other treatments.
<< 실험예Experimental Example 5> 주요 폴리페놀 성분 분석 5> Main polyphenol composition analysis
본 발명 감와인의 주요 폴리페놀 성분 분석을 위하여 와인 시료를 0.45 ㎛ membrane filter를 사용하여 여과한 후 HPLC(Jasco, Japan)로 분석하였다. 분석용 column으로는 SunFireTM-C18 (4.6×250 mm)를 사용하였고, Jasco MD-2010 Plus detector(Jasco, Japan)를 이용하여 UV 280 nm에서 분석하였다. Oven의 온도는 35℃였으며 사용된 용매는 A: 2% acetic acid in Water, B: 0.5% acetic acid in acetonitrile : water =50:50이었고, injection volume 20 ㎕, flow rate는 0.8 ml/min이었다. Wine samples were analyzed using 0.45 μm membrane filter and analyzed by HPLC (Jasco, Japan). SunFire as an analysis columnTM-C18 (4.6 × 250 mm) was used and analyzed at UV 280 nm using a Jasco MD-2010 Plus detector (Jasco, Japan). The temperature of the oven was 35 ° C. The solvents used were A: 2% acetic acid in Water, B: 0.5% acetic acid in acetonitrile: water = 50:50, 20 μl injection volume and 0.8 ml / min flow rate.
감와인의 주요 폴리페놀 성분은 [표 2]에 나타내었다. 폴리페놀 성분의 대부분을 차지하는 것이 gallic acid라는 것을 확인할 수 있었으며, catechin 및 epicatechin이 소량 검출되었다. 한편 폴리페놀 표준물질 및 처리구의 HPLC 크로마토그램을 도 2~도 5에 나타내었다. The main polyphenol components of persimmon wine are shown in [Table 2]. Gallic acid was found to occupy most of the polyphenols, and small amounts of catechin and epicatechin were detected. Meanwhile, HPLC chromatograms of polyphenol standards and treatments are shown in FIGS. 2 to 5.
한편, 본 발명 감와인의 monacolin K 함량을 분석한 결과는 도 6과 7에 나타내었다. monacolin K 함량은 약 1.3㎍/mL인 것으로 나타났다.
On the other hand, the results of analyzing the monacolin K content of the present invention wine is shown in Figures 6 and 7. The monacolin K content was found to be about 1.3 μg / mL.
<< 실험예Experimental Example 6> 미생물 검사 6> microbiological inspection
시료 1 mL를 취하여 멸균생리식염수를 이용한 10배 희석법으로 희석하고 일반세균용과 효모용 건조필름배지(Petri film, 3M, USA)에 각각 도말한 후 37℃에서 배양한 다음 나타난 colony를 계수하여 CFU/mL로 나타내었다. Take 1 mL of sample and dilute with 10-fold dilution method using sterile physiological saline, smear it on dry film medium for general bacteria and yeast (Petri film, 3M, USA), incubate at 37 ℃, and count the colony. Represented in mL.
감와인 제품 4종(2-1, 2-2, 추시 제품 375 mL, 750 mL)의 미생물 검사를 실시하여 [표 3]에 그 결과를 제시하였다. 일반세균은 네 처리구 모두 검출되지 않았으며, 효모균의 경우 2-2(2010년 3월 생산) 제품에서 3.3×102 CFU/mL 만큼 검출되었다. 한편, 본 발명 제품(750 mL)의 이화학적 특성 분석 결과 알코올 함량은 16.7%, 가용성고형물은 13.6 °Bx, 환원당은 3.95%, pH는 3.82인 것으로 나타났다.Microbiological tests were performed on four kinds of persimmon wine products (2-1, 2-2, follow-up products 375 mL, 750 mL) and the results are shown in [Table 3]. General bacteria were not detected in all four treatments, and yeast bacteria were detected by 3.3 × 10 2 CFU / mL in 2-2 (March 2010). On the other hand, the physicochemical characterization of the product (750 mL) showed that the alcohol content was 16.7%, the soluble solids was 13.6 ° Bx, the reducing sugar was 3.95%, and the pH was 3.82.
<< 실시예Example 2> 본 발명 2> present invention 감와인의Persimmon 농축 및 동결건조 Concentrate and Lyophilize
본 발명 감와인 1리터를 Evaporator 40℃조건에서 이틀 동안(48시간) 농축하여 알코올을 증발시켰다. 그 후 다시 이틀 동안(48시간) -40℃에서 동결건조하여 파우더 (68 g/liter)형태로 만든 후 본 발명 공시재료로 사용하였다. 상기 파우더는 다양한 제형을 위하여 식품공전에서 허용가능한 부형제와 혼합하여 시럽(Syrup)제품을 제조하거나, 타정하여 정(tablet)제품화 또는 식용가능한 캡슐에 넣어 캡슐제품화하여 건강보조식품으로 할 수 있었다.
One liter of the present invention wine was concentrated in an evaporator at 40 ° C. for two days (48 hours) to evaporate the alcohol. After lyophilization at -40 ° C for another two days (48 hours) to form a powder (68 g / liter) form was used as the present invention material. The powder was prepared by mixing with the excipients acceptable in the food industry for various formulations to produce a syrup (Syrup) product, or tableted into tablet products or capsules into edible capsules to be a dietary supplement.
<< 실험예Experimental Example 7> 세포배양 7> Cell Culture
세포실험을 위하여 H9c2 cardiac muscle cell을 American Type Culture Collection (Manassas, VA)에서 구입하였다. 세포를 Dulbecco’s modified Eagle’s medium (DMEM)에 10% fetal bovine serum을 첨가하여 37°C, 5% CO2 조건에서 배양하였다.
For cell experiments, H9c2 cardiac muscle cells were purchased from the American Type Culture Collection (Manassas, VA). Cells were added to Dulbecco ’s modified Eagle's medium (DMEM) with 10% fetal bovine serum at 37 ° C and 5% CO2 Cultured under conditions.
<< 실험예Experimental Example 8> 8> DPPHDPPH radicalradical scavengingscavenging assayassay
본 발명 감와인의 항산화능을 확인하기 위하여 DPPH라디칼 소거능을 측정하였다. 각각 농도의 시료와 DPPH용액(5 mg/100 ml methanol)을 동량으로 혼합한 다음 20분간 반응 시킨 후 525 nm에서 흡광도를 조사하였다. DPPH radical scavenging ability was measured to confirm the antioxidant capacity of the present invention. Each concentration of the sample and the DPPH solution (5 mg / 100 ml methanol) was mixed in the same amount and then reacted for 20 minutes and the absorbance at 525 nm was investigated.
추시와인의 항산화 활성을 평가하기 위하여 우선 DPPH radical 소거능을 평가하였다. 각각의 추시와인 자체의 항산화 활성과 추시와인 파우더의 항산화 활성을 도 16에 나타내었는데, 도 16A에서 보는 바와 같이 추시와인 자체는 0.125 μl에서 60%의 라디칼 소거능 활성을 나타내었고 1 μl에서는 거의 100%에 도달하여 5 μl까지 활성이 saturation되는 것을 확인할 수 있었다. 추시와인 파우더 역시 농도 의존적으로 라디칼 소거 능 활성을 나타내었고 200 μg/ml농도에서 100%의 활성을 나타내는 것을 확인할 수 있었다. 이상의 결과로 추시와인은 in vitro에서 항산화 활성이 뛰어난 것을 확인할 수 있었다.
First, DPPH radical scavenging ability was evaluated to evaluate the antioxidant activity of wine. The antioxidant activity of each follow-up wine itself and the antioxidant activity of the follow-up wine powder are shown in FIG. 16. As shown in FIG. 16A, the follow-up wine itself exhibited radical scavenging activity of 60% at 0.125 μl and almost 100% at 1 μl. It was confirmed that the activity was saturated up to 5 μl. Follow-up wine powder also showed a radical scavenging activity in a concentration-dependent manner, and showed 100% activity at a concentration of 200 μg / ml. As a result, it was confirmed that the follow-up wine had excellent antioxidant activity in vitro.
<< 실험예Experimental Example 9> 9> CellCell viabilityviability assayassay ( ( MTTMTT ))
세포를 96 well plate에 배양 한 후 각각의 시료를 처리 한다. 시료처리 종료 2시간 전에 MTT dye를 1 mg/ml로 처리 후 570 nm에서 흡광도를 측정한다.
Incubate the cells in 96 well plates and process each sample. Two hours before the end of the sample treatment, the absorbance was measured at 570 nm after treatment with 1 mg / ml of MTT dye.
<< 실험예Experimental Example 10> 10> ReactiveReactive oxygenoxygen speciesspecies ( ( ROSROS ) ) measurementmeasurement
세포를 6 well plate에 배양 한 후 각각의 시료를 처리한다. 시료처리 종료 30분전에 DCFH-DA dye를 10 μM로 30분 처리 후 세포배양액을 버린 뒤 PBS 1 ml을 넣은 후 green형광을 형광현미경을 통해 확인하여 ROS 생성여부를 판단한다.
Incubate the cells in 6 well plates and process each sample. Thirty minutes before the end of the sample treatment, the DCFH-DA dye was treated with 10 μM for 30 minutes, discarded the cell culture medium, and then 1 ml of PBS was added.
<< 실시예Example 3> 본 발명 3> invention 감와인의Persimmon 떫은맛 A bitter taste 저감을Reduction 위한 for 탄닌Tannins 성분 조절 Ingredient control
(1) 효소 처리 (1) enzyme treatment
감와인 중 감 특유의 떫은 맛을 감소시키기 위한 방안으로 탄닌분해효소인 tanninase를 첨가하여 반응시킨 후 주요 폴리페놀 성분을 조사하여 [표 4]에 제시하였다.In order to reduce the taste of persimmon in persimmon wine, the main polyphenol component was investigated after the reaction by adding tanninse, a tannin degrading enzyme, and presented in [Table 4].
상기 [표 4]에서 확인할 수 있듯이 검출된 성분인 gallic acid, catechin, epicatechin에서 세 처리구 모두 효소처리 전에 비해 효소처리 후 함량이 감소된 것을 확인할 수 있었다. 따라서 효소처리 방법은 감와인의 떫은 맛 개선을 위한 효과적인 방안이 될 수 있을 것으로 판단되었다. 단, tanninase 효소의 높은 가격문제는 사용 여부에 영향을 줄 수 있는 요인이 될 것으로 생각된다. 도 8~10에 각 처리구의 효소처리 후 HPLC 크로마토그램을 나타내었다.
As can be seen in [Table 4] it was confirmed that the content of the three components treated with gallic acid, catechin, epicatechin after the enzyme treatment was reduced compared to before the enzyme treatment. Therefore, the enzyme treatment method could be an effective way to improve the astringent taste of persimmon wine. However, the high price of tanninase enzyme may be a factor that can affect the use. 8 to 10 show HPLC chromatograms after enzymatic treatment of each treatment.
(2) 젤라틴 처리 방법(2) gelatin treatment method
탄닌 성분은 수용성으로 단백질과 결합하여 변성시키는 작용이 있으므로, 동물의 가죽 ·힘줄 ·연골 등을 구성하는 천연 단백질인 콜라겐을 뜨거운 물로 처리하면 얻어지는 유도 단백질의 일종인 젤라틴을 감와인에 일정량 첨가한 후 주요 폴리페놀 성분의 변화를 조사하였다. 젤라틴 처리는 감와인 “2-1 (2009년 2월 생산)” 제품에 가루 젤라틴 0.3중량%를 첨가하고 60분 동안 교반한 후 0.45 ㎛ membrane filter에 여과하여 실험에 사용하였다. [표 5]에 그 결과를 제시하였다. Since tannin is water-soluble, it binds to proteins and denatures them. Therefore, after a certain amount of gelatin, a derivative of protein derived from the treatment of collagen, a natural protein that constitutes animal skin, tendons, cartilage, etc. with hot water, The change in the polyphenol component was investigated. Gelatin treatment was used in the experiment by adding 0.3% by weight of powdered gelatin to the gamma wine "2-1 (February 2009)" product, stirred for 60 minutes and filtered through a 0.45 ㎛ membrane filter. The results are shown in [Table 5].
검출된 세 성분 gallic acid, catechin, epicatechin의 함량 비교 결과 젤라틴 처리 후의 감와인의 폴리페놀 성분이 감소된 것을 확인할 수 있었으며, 특히 gallic acid의 경우 157.5 /mL에서 84.3 /mL로 급격하게 감소된 것을 확인하였다. 따라서 효소처리 방법의 가격 등의 문제를 고려할 때 젤라틴 처리 방법도 탄닌 감소의 유용한 대안이 될 수 있을 것으로 판단되었다. 도 11에 감와인 제품의 젤라틴 처리 후의 HPLC 크로마토그램을 나타내었다. 본 발명의 원료에 효소처리 또는 젤라틴을 전처리하여 떫은 맛 성분을 제거하는 것은 gallic acid 등의 유효성분의 큰 변화없이 건강 기능성 보조식품 원료로서 변비를 예방할 필요가 있는 경우에 반드시 필요하다 할 것이다.
As a result of comparing the detected three components of gallic acid, catechin, and epicatechin, it was confirmed that the polyphenol component of persimmon wine was decreased after gelatin treatment. Especially, the gallic acid was rapidly reduced from 157.5 / mL to 84.3 / mL. . Therefore, gelatin treatment method may be a useful alternative to tannin reduction in consideration of problems such as price of enzyme treatment method. Fig. 11 shows the HPLC chromatogram after gelatin treatment of a gamma wine product. Pretreatment of the raw material of the present invention with enzyme treatment or gelatin to remove the astringent taste components will be necessary in the case of the need to prevent constipation as a health functional supplement raw material without significant changes in active ingredients such as gallic acid.
<< 실험예Experimental Example 11> 11> 감와인Gam wine 제조 과정에 따른 품질 특성 경시적 변화 Changes in Quality Characteristics over Time by Manufacturing Process
본 발명 감와인으로 제조되는 과정에서 일어나는 이화학적 특성 변화를 조사하고자 연시 생것과, 감와인 제조 과정 중 홍국균을 접종한 1차 발효단계와 효모를 접종하여 발효하는 2차 발효단계의 세 처리구를 비교하여 이화학적 특성 및 주요 폴리페놀 성분을 분석한 결과는 [표 6] 및 [표 7]과 같다. To investigate the change in physicochemical properties occurring in the process of producing persimmon wine of the present invention The results of analyzing the chemical properties and main polyphenol components are shown in [Table 6] and [Table 7].
알코올 함량은 홍국발효에서 효모발효단계로 진행될수록 증가하는 결과를 보였고, 가용성고형물, 환원당, pH의 경우 연시에 비해 1차 발효단계에서 모두 감소하였지만 2차 발효단계로 진행될수록 다시 증가하는 결과를 나타내었다.Alcohol content increased as the yeast fermentation stage increased in the fermentation of red yeast rice. Soluble solids, reducing sugars, and pH decreased in the first fermentation stage compared with the year-end, but increased again as the fermentation stage proceeded. It was.
폴리페놀 성분은 연시에서 와인 발효 단계로 진행되면서 gallic acid는 증가하였고, catechin, epicatechin, gallocatechin, gallocatechin gallate, catechin gallate는 감소한 결과를 나타내었다. 감과실에 존재하는 탄닌은 기본구조가 catechin과 gallocatechin 등을 골격으로 한 proanthocyanidin의 polymer로서 그 측쇄에 gallic acid가 ester 결합을 한 것이라고 생각된다. 따라서 발효에 따른 자연 탈삽현상에 의해 catechin류 성분의 함량은 감소하고 catechin 분해에 따른 gallic acid의 증가 현상이 일어난 것으로 추측된다.As the polyphenol component progressed from the wine fermentation stage, gallic acid increased and catechin, epicatechin, gallocatechin, gallocatechin gallate and catechin gallate decreased. Tannin in persimmon fruit is a polymer of proanthocyanidin whose basic structure is catechin and gallocatechin, etc., and it is thought that gallic acid has ester bond in its side chain. Therefore, the content of catechin components is decreased due to the natural desorption phenomena during fermentation, and the increase of gallic acid by catechin decomposition is estimated.
도 12~15에 연시 및 1, 2차 발효단계의 와인에 대한 HPLC 크로마토그램을 나타내었다.
12 to 15 show HPLC chromatograms for the year-round and first and second fermentation wines.
<< 실험예Experimental Example 12> 본 발명 12> present invention 감와인의Persimmon 세포모델에서 활성산소 Free radicals in cell models 제거능Removability 평가 evaluation
심장질환은 여러 가지 원인에 의해서 발병되고 인간의 생존에 위협이 되는 중요한 질환중 하나이며 많은 심장질환의 발병 인자 중 활성산소는 심장의 ischemia/reperfusion시 발생하여 세포에 손상을 주는 것으로 알려져 있다. 이에 따라 본 발명의 추시와인의 in vitro 항산화 활성결과를 토대로 심장세포모델을 이용하여 세포내 활성산소(ROS)의 제거에도 효능이 있는지를 평가하였다. H9c2심장근육세포에 추시와인 파우더를 농도의존적으로 (10-800 μg/ml) 1시간동안 전 처리 한 후 H2O2 500 μM을 4시간동안 처리하여 ROS의 생성을 유도하였다. 이때 DCFH-DA dye를 10 μM로 30분 처리 후 green형광을 형광현미경을 통해 확인한 결과, 아무것도 처리하지 않은 세포(None)에서는 형광이 나타나지 않았고 H2O2를 처리 시 (0) 세포가 green형광을 나타내었으며 이때 추시와인 파우더는 농도의존적으로 H2O2 에 의해 유도된 ROS를 제거할 수 있음을 알게 되었다(도 17). 이상의 결과로 본 발명 추시와인은 in vitro뿐만 아니라 세포모델에서도 항산화 활성이 뛰어난 것을 확인할 수 있었다.
Heart disease is caused by various causes and is one of the important diseases that threaten human survival. Among the pathogens of many heart diseases, free radicals are known to cause damage to cells due to cardiac ischemia / reperfusion. Accordingly, based on the results of in vitro antioxidant activity of the wine of the present invention, the cardiac cell model was used to evaluate the efficacy of intracellular free radicals (ROS) removal. H9c2 cardiac muscle cells were pretreated with follow-up wine powder concentration-dependently (10-800 μg / ml) for 1 hour and then H2O2 500 μM was treated for 4 hours to induce the production of ROS. At this time, the green fluorescence was confirmed by fluorescence microscopy after 30 minutes of DCFH-DA dye treatment with 10 μM.2O2(0) cells showed green fluorescence when treated, and the follow-up wine powder was H-dependent.2O2 It was found that ROS induced by can be removed (FIG. 17). As a result, the present invention was able to confirm that the present invention has excellent antioxidant activity in cell model as well as in vitro.
<< 실험예Experimental Example 13> 본 발명 13> present invention 추시와인의Follow-up wine HH 22 OO 22 유도된 Induced 심장세포사멸의Cardiac apoptosis 보호효과 Protective effect
다음으로 심장세포모델을 이용하여 추시와인이 H2O2 유도된 세포사멸에 있어서 보호능이 있는지를 평가하기 위해 다음과 같은 실험을 실시하였다. H9c2심장근육세포에 추시와인 파우더를 농도의존적으로 (10-800 μg/ml) 1시간동안 전 처리 한 후 H2O2 500 μM을 4시간동안 처리하여 세포사멸을 유도하였다. 이때 실험 종료 2시간 전 MTT dye를 1 mg/ml로 처리 후 흡광도를 측정한 결과 아무것도 처리하지 않은 세포(None)에비해 H2O2를 처리 시 (0) 세포의 사멸이 유도됨을 볼 수 있었으며 추시와인 파우더는 100 μg/ml의 농도에서부터 유의적으로 800 μg/ml농도까지 H2O2 에 의해 유도된 세포사멸을 억제하고 있음을 알게 되었다(도 18A, B). 이상의 결과로 추시와인은 세포모델에서도 항산화 활성 및 세포보호효과가 뛰어난 것을 확인할 수 있었다.
Next, using the heart cell model, the follow-up wine was H2O2 The following experiments were conducted to evaluate whether there is protection in induced apoptosis. H9c2 cardiac muscle cells were pretreated with follow-up wine powder concentration-dependently (10-800 μg / ml) for 1 hour and then H2O2 500 μM was treated for 4 hours to induce apoptosis. At this time, 2 hours before the end of the experiment, MTT dye was treated with 1 mg / ml, and the absorbance was measured.2O2Treatment with (0) showed that cell death was induced. In the follow-up wine powder, concentrations from 100 μg / ml to significantly 800 μg / ml were observed.2O2 It was found that the cell death induced by the cells was suppressed (FIGS. 18A and B). As a result, the follow-up wine was found to have excellent antioxidant activity and cytoprotective effect in the cell model.
<< 실험예Experimental Example 14> 본 발명 14> present invention 추시와인Follow-up wine majormajor compoundscompounds 의 of 심장세포Cardiac cell 보호효능 평가 Protective efficacy evaluation
다음으로 본 발명 추시와인의 주요성분을 분석하였고, 그중 Gallic acid와 Monacolin K가 추시와인의 심장세포 보호효능에 중요한 역할을 하는지를 평가하였다. H9c2심장근육세포에 gallic acid또는 Monacolin K를 농도의존적으로 (10-200 μM) 1시간동안 전 처리 한 후 H2O2 500 μM을 4시간동안 처리하여 세포의 사멸을 유도하였다. 이때 실험 종료 2시간전 MTT dye를 1 mg/ml로 처리 후 흡광도를 측정한 결과, 본 발명 감와인과 파우더의 성분 gallic acid와 Monacolin K중 gallic acid가 농도의존적으로 H2O2 에 의해 유도된 세포사멸을 억제하고 있음을 알게 되었다(도 19). 이상의 결과로 본 발명 감와인의 심장세포 보호효능은 아마도 gallic acid가 중요한 성분으로 작용할 것이라 추론할 수 있었다.
Next, the main components of the present invention wine were analyzed, and among them, Gallic acid and Monacolin K were evaluated to play an important role in the cardioprotective effect of the wine. H9c2 cardiomyocytes were treated with gallic acid or Monacolin K in concentration-dependent (10-200 μM) for 1 hour before H2O2 500 μM was treated for 4 hours to induce cell death. At this time, 2 hours before the end of the experiment, MTT dye was treated with 1 mg / ml, and the absorbance was measured. As a result, the concentration of gallic acid and gallic acid in Monacolin K of the persimmon wine powder of the present invention2O2 It was found that the cell death induced by the cells was suppressed (FIG. 19). As a result, it could be inferred that gallic acid acts as an important component of the protective effect of the present invention.
본 발명은 폐기되는 떫은 감 또는 연시의 파쇄액(펄프)을 재활용하여 항산화 기능성 식품 조성물 및 심장보호 기능성 식품을 제공하는 뛰어난 효과가 있으므로 식품가공산업상 매우 유용한 발명인 것이다.The present invention is a very useful invention in the food processing industry because it has an excellent effect of providing an antioxidant functional food composition and a cardioprotective functional food by recycling waste shredded persimmon or soft waste (pulp).
Claims (3)
After sterilization of the crushed persimmon crushed solution of the fruit or new year, inoculated with the pre-culture of the Monascus perprius KCCM 60170 strain to the sterilized raw materials, and then fermented to 23 o Brix after juice and filtration Second fermentation was inoculated with yeast inoculation to Mises cerevisiae yeast until the alcohol content was reached 16%, and it was obtained by treating and aging tannin degrading enzyme or gelatin, concentrating for 48 hours at 40 ℃, and lyophilizing at -40 ℃ for 48 hours. Fermented persimmon wine powder of red yeast bacteria and yeast in the yeast.
Antioxidant and cardioprotective functional food composition comprising the persimmon wine powder of claim 1 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110079838A KR20130017431A (en) | 2011-08-10 | 2011-08-10 | An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110079838A KR20130017431A (en) | 2011-08-10 | 2011-08-10 | An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130017431A true KR20130017431A (en) | 2013-02-20 |
Family
ID=47896588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110079838A KR20130017431A (en) | 2011-08-10 | 2011-08-10 | An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20130017431A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105062739A (en) * | 2015-07-20 | 2015-11-18 | 合肥维巧食品科技有限公司 | Method for manufacturing solid red wine beverage |
KR20160072707A (en) * | 2014-12-15 | 2016-06-23 | 양촌감 영농조합법인 | persimmon beverage product fortified polyphenol ingredient and preparation method thereof |
KR20210043343A (en) * | 2019-10-11 | 2021-04-21 | 서종석 | Fermented Persimmon Extract for Anti-obesity and preparation menthod of the same |
-
2011
- 2011-08-10 KR KR1020110079838A patent/KR20130017431A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160072707A (en) * | 2014-12-15 | 2016-06-23 | 양촌감 영농조합법인 | persimmon beverage product fortified polyphenol ingredient and preparation method thereof |
CN105062739A (en) * | 2015-07-20 | 2015-11-18 | 合肥维巧食品科技有限公司 | Method for manufacturing solid red wine beverage |
KR20210043343A (en) * | 2019-10-11 | 2021-04-21 | 서종석 | Fermented Persimmon Extract for Anti-obesity and preparation menthod of the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meng et al. | Phenolic characterization of young wines made from spine grape (Vitis davidii Foex) grown in Chongyi County (China) | |
CN110029034A (en) | A kind of green liquor and preparation method thereof of combination glutinous rice diastatic fermentation | |
CN106010872B (en) | Preparation method of mangosteen fruit wine | |
CN110731436B (en) | Black tiger acetic acid beverage as well as preparation method and application thereof | |
KR20170045074A (en) | The Productive Method of Fremenatation Beverage and cosmetic ingredients with Gynura Procumbens | |
KR101670649B1 (en) | A method for preparation of mixed composition with fermented medical plants extracts | |
KR101246574B1 (en) | Manufacturing method for making high quality cherry wine with various varieties or enzyme treatment | |
Osiripun et al. | Polyphenol and antioxidant activities of Kombucha fermented from different teas and fruit juices | |
KR20190138066A (en) | kombucha manufacturing method | |
KR102012872B1 (en) | High concentrate for beverage containing black raspberry, plantaginis asiatica l., schizandra chinensis, lycii fructus and torilis japonica decandolle and the high concentrate for beverage prepared from the same | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
KR20130017431A (en) | An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain | |
KR20200128998A (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg | |
KR100423537B1 (en) | The physiofunctional fermented liquor with chaenomeles sinensis and the producing method of therof | |
Minh | Investigation of mangrove apple (Sonneratia caseolaris) juice production | |
Jain et al. | Development and screening of byproduct for its secondary metabolites, antioxidant and anti-diabetic potential from anthracnose-infected fruits of pomegranate: a sustainable approach | |
KR100795997B1 (en) | Rubus coreanus(bokbunja) wine supplemeted with prunus mume(maesil) sugar leachate and preparing method of the same | |
CN116515586A (en) | Tartary buckwheat health wine with anti-inflammatory and antioxidant properties and preparation method thereof | |
KR20130017432A (en) | An anticancer composition of persimmom wine powder using monascus purpureus spp. strain | |
KR101620939B1 (en) | Method for preparing antiobese natural fermented vinegar using dendropanax morbiferum leveille and pear | |
KR101203096B1 (en) | Producing method for fermented wild grass extracts with biological activity | |
KR20050092155A (en) | The preperation method of mulberrry liquor | |
KR20190059536A (en) | Beverage composition of Aronia melanocarpa containing active ginsenosides and preparation method thereof | |
KR20130008823A (en) | An improving method for antioxidant activity of extracts derived from natural herbal material and their application to cosmetic composition for the prevention of aging or medical composition for antioxidation and anti-inflammation | |
KR101245191B1 (en) | Extract of fermented wild dropwort for stimulating hepatic function and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |